针剂量及其与慢性稳定胸痛患者疗效的相关性:随机对照试验的系统审查和元分析
Dajun Huang1, Yanwei Li1, Xiaoyan Zheng2,3
1Department of Cardiovascular Medicine, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, People's Republic of China.
Journal of pain research
|January 15, 2025
概括
针有效地减少慢性稳定性心痛 (CSA) 发作. 适量针显示出最有希望的症状缓解,表明了优化治疗方案的潜力.
科学领域:
- 综合医学是一个整体的医学.
- 心脏病学 心脏病学
- 基于证据的实践.
背景情况:
- 慢性稳定性心脏病 (CSA) 的管理仍然是一个临床挑战.
- 针在CSA中的作用被建议,但最佳剂量尚不清楚.
- 需要随机对照试验 (RCT) 来澄清针的疗效和剂量关系.
研究的目的:
- 系统地审查和比较不同针剂量对慢性稳定性心脏病 (CSA) 的疗效.
- 分析针剂量参数与CSA患者治疗有效性之间的关系.
- 评估针在CSA管理中的安全概况.
主要方法:
- 对将针与安慰剂或CSA标准护理进行比较的RCT进行系统审查.
- 研究被分为低 (LDG),中等 (MDG) 和高 (HDG) 剂量组,根据针点,疗程和频率进行分类.
- 主要结局是心痛发作频率的变化;安全性也被评估.
主要成果:
- 与安慰剂和标准护理相比,针显著减少了心痛发作 (P<0.0001).
- 中度剂量针 (MDG) 显示,心痛发作 (SMD, -0.60;P=0.001) 的显著减少.
- 低 (LDG) 和高 (HDG) 剂量没有显著的疗效,并且在不同组中没有报告任何显著的不良事件.
结论:
- 针是缓解CSA症状的有效和安全疗法.
- 适度的针剂量似乎最有利于降低CSA的症状.
- 进一步的研究应该专注于优化针剂量,以改善CSA治疗结果.
相关概念视频
01:16Antianginal Drugs: Nitrates and β-Blockers
512
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
512
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
451
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
451